5 December 2017Europe

Horizon Discovery expands CRISPR licence with ERS Genomics

UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

CRISPR in Europe: the patent landscape for 2018

30 November 2017 The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR.

EPO grants second CRISPR patent to ERS Genomics

7 March 2018 The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology.

Horizon partners with big pharma company on CRISPR

29 August 2018 UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.

More on this story

Horizon partners with big pharma company on CRISPR

29 August 2018 UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.

CRISPR in Europe: the patent landscape for 2018

30 November 2017 The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR.

EPO grants second CRISPR patent to ERS Genomics

7 March 2018 The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology.

More on this story

Horizon partners with big pharma company on CRISPR

29 August 2018 UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.

CRISPR in Europe: the patent landscape for 2018

30 November 2017 The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR.

EPO grants second CRISPR patent to ERS Genomics

7 March 2018 The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent